Women with thrombophilia (all other thrombophilias, except homozygous factor V Leiden and mutation of prothrombin 20210 homozygous), with no past thromboembolism, and with no family history of thrombosis should perform clinical vigilance during pregnancy and during puerperium: 92% agreement. This evidence concerns the gene F2 and thrombophilia.